Junctional Ectopic Tachycardia
Junctional Ectopic Tachycardia: rare; congenital or post surgery for congenital heart disease; abnormal automaticity within the His bundle; high mortality rate (35%)
Junctional Ectopic Tachycardia: rare; congenital or post surgery for congenital heart disease; abnormal automaticity within the His bundle; high mortality rate (35%)
Implantable Cardioverter Defibrillators (ICDs): implantable device defibrillator +/- pacemaker (counter shock vector is from RV -> both SVC)
Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiac disorders (affecting ~ 1 in 500 people) and is the number one cause of sudden cardiac death in young athletes. Annual mortality is estimated at 1-2 %.
Criteria for heart transplant recipient
Follath F, et al; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002 Jul…
Heart Block and Conduction Abnormalities with first, second, third degree blocks; and fascicular blocks
nasal intubation may be performed blind or with fiberoptic assistance. Indicated when oral intubation is not feasible
Cardiac Output (CO) = Stroke Volume (SV) x Heart rate (HR) CO = SV x HR changes based on exercise, age and body size. normal adult = 5L/min Stroke Volume (SV) determined by: Preload Afterload Contractility
Cardiac Lesions and Severe Clinical Signs; valvular issues, cardiac anomalies and their murmurs
Biomarkers can potentially be used to detect and monitor a wide range of cardiac conditions in the critical care setting
THERAPEUTIC HYPOTHERMIA AND TARGETED TEMPERATURE MANAGEMENT Nielsen N, et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 2013 Dec 5;369(23):2197-206. [PMID 24237006] MCRCT without allocation concealment 36 ICUs in Europe and Australia n…
The use of Beta-blockers in perioperative medicine has been an issue of intense research in Anaesthesia. Patients that are believed to benefit from beta-blockers are those with risk factors for ischaemic heart disease (HT, DM, hypercholesterolaemia, previous MI, angina, controlled heart failure)